company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,85713000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,85713000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22529000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22529000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,63184000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60837000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25954000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,88260000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25076000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6762000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18353000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,671000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19024000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19024000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19024000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28529000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28529000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22681000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16888000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6843000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,361000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24092000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1411000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-126000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-118000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1529000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,243000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1772000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1772000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1772000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,101151000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,101151000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21977000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21977000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,79174000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62287000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26677000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1395000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,90359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11185000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,465000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-143000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,322000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,892000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11755000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11755000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11755000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,72622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,72622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16129000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16129000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56493000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45399000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19834000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1034000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66267000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9774000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,457000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,440000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9334000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,649000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9983000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9983000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9983000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27244000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27244000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5437000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5437000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21807000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15592000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6592000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,295000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22479000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-672000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,34000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-638000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,164000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,45378000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,45378000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10692000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10692000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34686000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29807000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13242000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,739000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9102000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,453000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-47000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,406000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,485000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9181000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9181000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9181000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37156000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37156000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23376000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23376000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5408000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5408000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17968000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14054000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6589000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,372000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21015000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3047000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,216000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-128000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,88000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2959000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,242000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37156000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37156000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22002000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22002000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5284000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5284000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16718000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15753000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6653000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,367000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22773000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6055000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,237000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,81000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5737000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,243000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37086000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37344000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37344000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6786000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6786000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20028000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7236000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,352000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27616000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2942000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2928000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,361000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,126375000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,126375000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24507000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24507000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,101868000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,71711000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27159000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1478000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,100348000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1520000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2543000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1048000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1495000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1495000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1495000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89031000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89031000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17721000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17721000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,71310000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51683000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1126000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72732000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1422000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1013000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1037000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-385000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,687000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1072000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1072000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1072000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38498000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,117560000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,117560000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23569000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23569000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93991000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68571000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26766000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1487000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,96824000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2833000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1021000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-102000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,919000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1914000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,930000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2844000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2844000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2844000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38498000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6279000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6279000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25919000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17184000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,362000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23686000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2233000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1015000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1054000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3287000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,366000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38498000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56833000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56833000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11442000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11442000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45391000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34499000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13783000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,764000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49046000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3655000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3672000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,321000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39366000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,112606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,112606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22727000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22727000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89879000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66979000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27218000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1420000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,95617000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5738000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-111000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-101000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,728000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39366000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29478000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29478000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23927000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16323000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6459000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,379000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23161000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,766000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-6000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,66000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,60000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,225000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39366000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,106504000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,106504000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22584000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22584000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,83920000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64710000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27348000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1413000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,93471000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,232000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-305000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-73000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9624000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,745000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10369000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10369000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10369000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38268000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38268000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27355000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27355000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5891000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5891000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21464000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18176000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7324000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,385000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25885000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4421000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-81000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-77000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4498000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,96000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38268000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38268000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43674000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43674000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23894000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6822000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30716000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4132000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,398000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39113000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41052000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,158124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,158124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31596000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31596000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,126528000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,84227000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25647000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,111000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,109985000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16543000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,326000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,319000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39113000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41052000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,114450000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,114450000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22770000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22770000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,91680000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60333000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18825000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,111000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79269000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12411000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,311000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,311000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12722000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1450000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39417000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40865000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,151794000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,151794000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29556000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29556000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,122238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,80361000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26061000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,463000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,106885000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15353000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,296000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,297000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15650000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39417000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40865000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30120000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20943000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6259000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27202000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2918000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,324000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,325000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3243000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,559000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39417000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40865000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,76200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,76200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14640000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14640000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,61560000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39390000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12566000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,111000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52067000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9493000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9479000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,891000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8588000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8588000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8588000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39431000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41722000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,145742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,145742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27705000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27705000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,118037000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,76602000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25942000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,825000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,103369000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14668000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1015000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1026000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15694000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1618000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14076000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14076000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14076000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39431000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41722000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37417000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37417000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7194000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7194000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30223000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18437000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5854000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24291000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5932000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5924000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39431000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.14
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41722000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.14
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,137803000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,137803000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,111741000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,74488000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26547000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1204000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,102239000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9502000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1008000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,86000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1094000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10596000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1388000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39144000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41549000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38783000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38783000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31337000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20953000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6712000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,111000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27776000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3561000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39144000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41549000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,183643000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,183643000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37322000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37322000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,146321000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,107251000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30707000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,137958000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,118000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,49000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8530000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1179000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7351000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7351000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7351000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39334000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50433000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50433000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10114000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10114000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40319000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28721000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7920000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36641000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,44000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,84000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3762000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39334000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,133210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,133210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,106002000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,78530000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22787000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101317000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4685000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,78000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,83000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4768000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1039000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3729000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3729000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3729000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39592000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41726000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,176884000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,176884000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36034000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36034000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,140850000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,102424000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29609000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,132033000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8817000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,71000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,91000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8908000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1437000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7471000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7471000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7471000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39592000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41726000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9458000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9458000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36737000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24364000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7779000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32143000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,37000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,57000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4651000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,258000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39592000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41726000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,87015000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,87015000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,69265000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54166000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15008000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69174000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,91000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,41000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,117000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,781000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-664000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-664000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-664000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39260000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41337000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,168939000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,168939000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34706000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34706000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,134233000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,99003000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28089000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,127092000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7141000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,324000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1738000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5762000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5762000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5762000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39260000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41337000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44345000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44345000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9027000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9027000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26199000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7721000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33920000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1398000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,31000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1429000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,370000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39260000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41337000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,162011000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,162011000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,129138000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,91241000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,117463000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11675000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,309000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,320000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1823000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42670000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42670000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33947000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27967000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7287000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35254000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1307000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-21000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1312000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,411000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,230311000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,230311000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39945000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39945000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,190366000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,125727000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,161700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28666000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,196000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-97000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,99000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28765000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-84923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,113688000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,113688000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,113688000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40632000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.8
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42858000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.65
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.8
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,67557000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,67557000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10806000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10806000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56751000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34535000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9853000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44388000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-59000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12372000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-86502000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,98874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,98874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,98874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40632000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.44
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42858000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.44
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,162754000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,162754000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29139000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29139000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,133615000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,91192000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26120000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,117312000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16303000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,128000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,90000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1579000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40856000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42884000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,213187000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,213187000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39253000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39253000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,173934000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,119913000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34040000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,153953000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,19981000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,168000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,174000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1719000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40856000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42884000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,62005000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,62005000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9838000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9838000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30139000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38504000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13663000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,48000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,38000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13701000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1017000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40856000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42884000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,100749000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,100749000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19301000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19301000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81448000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61053000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17755000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78808000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2640000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,80000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-28000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,52000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2692000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,562000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40448000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42239000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,197377000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,197377000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,158504000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,114138000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33454000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,147592000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10912000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,157000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,36000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11105000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,960000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10145000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10145000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10145000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40448000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42239000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51938000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51938000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9612000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9612000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42326000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8693000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38148000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4178000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,36000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4175000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,336000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40448000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42239000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,189784000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,189784000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,151496000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,110882000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32482000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,143364000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8132000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,146000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,81000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,227000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9689000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9689000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39122000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31598000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40660000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1538000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,55000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1483000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,226000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,329543000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,329543000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,50419000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,50419000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,279124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,164261000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49759000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,214020000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,65104000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,395000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,339000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,734000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65838000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27691000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,38147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,38147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,38147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42204000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.9
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.85
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.9
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,93957000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,93957000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14663000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14663000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,79294000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14225000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59481000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,19813000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,186000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,228000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,414000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20227000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9229000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42204000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,85795000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,85795000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12744000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12744000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,73051000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41853000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13755000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55608000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17443000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,84000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-29000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,55000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17498000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6943000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42427000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44949000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,235586000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,235586000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35756000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35756000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,199830000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,119005000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35534000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,154539000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45291000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,209000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,111000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,320000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,45611000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18462000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27149000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27149000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27149000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42427000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.64
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44949000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.6
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.64
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,303143000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,303143000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46562000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46562000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,256581000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,153540000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45387000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,198927000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,57654000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,277000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,52000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,329000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,57983000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-68040000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,126023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,126023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,126023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42427000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44949000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.9
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,76359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,76359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12144000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12144000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,64215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39829000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11569000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51398000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12817000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,62000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,87000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,149000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12966000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5231000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42228000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44922000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,149791000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,149791000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23012000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23012000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,126779000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,77152000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21779000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,98931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,27848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,265000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28113000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11519000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42228000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44922000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,279353000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,279353000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43656000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43656000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,235697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,141826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39997000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,181823000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,241000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,71000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,312000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,54186000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-73966000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,128152000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,128152000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,128152000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42228000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.14
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44922000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.97
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.14
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,73432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,73432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10868000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10868000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,62564000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37323000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47533000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15031000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,63000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,53000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44410000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,254932000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,254932000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,41124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,41124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,213808000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,131452000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37121000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,168573000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45235000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-55000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,45395000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-78861000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,124256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,124256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,124256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44410000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.89
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,445304000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,445304000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,70627000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,70627000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,374677000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,218153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,66386000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,284539000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,90138000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1554000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-349000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1205000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,91343000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,39227000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,52116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,52116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44658000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.17
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,124680000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,124680000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19261000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19261000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,105419000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16325000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76425000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,486000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,362000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29356000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14457000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44658000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,114674000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,114674000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18987000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18987000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,95687000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53935000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16349000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70284000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25403000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,457000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,423000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10394000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43431000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44770000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,320624000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,320624000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,51366000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,51366000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,269258000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,158053000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50061000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,208114000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61144000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1068000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-225000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,843000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,61987000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24770000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43431000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.87
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44770000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.87
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,414581000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,414581000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,66029000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,66029000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,348552000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,203309000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,64286000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,267595000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,80957000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1254000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1257000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,82214000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,33999000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,48215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43431000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.13
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44770000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.13
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102955000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102955000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17309000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17309000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85646000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53086000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18052000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71138000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14508000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,342000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-114000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,228000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14736000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5861000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43129000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44580000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,205950000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,205950000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32379000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32379000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,173571000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,104118000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33712000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,137830000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35741000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,611000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-191000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,420000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36161000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14376000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21785000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21785000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21785000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43129000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44580000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,385702000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,385702000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,59786000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,59786000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,325916000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,191227000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,61692000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,252919000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,72997000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,881000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,889000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,73886000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,30548000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43338000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43338000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43338000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43129000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44580000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15070000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15070000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,87925000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51032000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15660000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66692000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21233000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,269000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-77000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,192000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21425000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8515000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12910000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12910000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12910000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45178000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,359106000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,359106000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,54621000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,54621000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,304485000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,177970000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,55209000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,233179000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,71306000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,209000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,810000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,72116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29918000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,42198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.99
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45178000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.94
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.99
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,593749000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,593749000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,98581000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,98581000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,495168000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,262734000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,75297000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,338031000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,157137000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3688000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-388000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,160437000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,48267000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,112170000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,112170000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,112170000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.54
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45849000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.45
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.54
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,174436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,174436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30098000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30098000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,144338000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,75501000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,96771000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,47567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1303000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,940000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48507000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11660000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,36847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,36847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45849000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.8
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,154022000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,154022000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,129028000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66556000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17706000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,84262000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44766000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,969000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-81000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,888000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,45654000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44247000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45869000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,419313000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,419313000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,68483000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,68483000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,350830000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,187233000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54027000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,241260000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,109570000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2385000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2360000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,111930000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,36607000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,75323000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,75323000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,75323000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44247000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.71
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45869000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.65
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.71
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,543993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,543993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,87744000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,87744000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,456249000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,247333000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,70352000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,317685000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,138564000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2871000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-149000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2722000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,141286000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,51064000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,90222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,90222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44247000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45869000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.99
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,132823000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,132823000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21627000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21627000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,111196000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60080000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19390000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79470000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31726000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,781000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,758000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32484000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7981000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44141000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45698000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,265291000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,265291000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43489000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43489000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,221802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,120677000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36321000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,156998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,64804000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1416000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,56000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1472000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66276000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4399000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61877000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,61877000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,61877000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44141000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.41
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45698000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.36
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.41
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,504645000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,504645000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,81737000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,81737000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,422908000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,234712000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,68995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,303707000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,119201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-102000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2257000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,121458000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,92208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,92208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,92208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44141000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45698000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,132468000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,132468000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,110606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60597000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77528000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33078000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,635000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,79000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,714000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33792000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3582000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.85
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45608000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.82
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.85
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,474777000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,474777000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,77419000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,77419000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,397358000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,227718000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,67657000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,295375000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,101983000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1920000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1727000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,103710000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76580000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,76580000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,76580000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.76
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45608000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.7
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.76
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,769432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,769432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,129567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,129567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,639865000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,321550000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,93503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,415053000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,224812000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8166000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,38548000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,263360000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4344000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,259016000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,259016000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,259016000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44911000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.77
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46151000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.61
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.77
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,207081000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,207081000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,172233000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,81296000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25548000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,106844000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,65389000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2769000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30372000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,33141000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,98530000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24596000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73934000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,73961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,73961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44911000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.64
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46151000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.6
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.64
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200563000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200563000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,166540000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,80220000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23965000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,104185000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,62355000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2175000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,64510000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19648000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,44862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,44862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45046000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46136000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,562351000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,562351000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,94719000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,94719000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,467632000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,240254000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,67955000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,308209000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,159423000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5397000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5407000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,164830000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-20252000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,185082000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,185055000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,185055000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45046000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.13
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46136000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.01
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.13
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,736787000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,736787000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,124817000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,124817000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,611970000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,315755000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,89225000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,404980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,206990000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-353000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6347000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,213337000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8592000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,221929000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,221902000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,221902000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45046000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.96
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46136000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.81
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.96
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,181778000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,181778000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29846000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29846000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,151932000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,78895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22717000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101612000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,50320000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1671000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-158000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1513000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51833000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50133000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,50127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,50127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,361788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,361788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,60696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,60696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,301092000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,160034000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43990000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,204024000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,97068000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3252000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,100320000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-39900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,140220000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,140193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,140193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.13
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.13
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,690246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,690246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,115788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,115788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,574458000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,302091000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,82966000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,385057000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,189401000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5494000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-414000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5080000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,194481000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3968000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,190513000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,190486000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,190486000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.13
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,180010000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,180010000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30850000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30850000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,149160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,81139000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21273000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,102412000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,46748000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,188000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1739000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48487000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-41600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90087000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,90066000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,90066000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44546000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46169000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.95
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,641291000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,641291000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,107569000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,107569000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,533722000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,283276000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,79639000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,362915000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,170807000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4604000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-279000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4325000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,175132000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10249000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,164883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,164862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,164862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44546000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.71
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46169000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.58
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.71
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,206659000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,206659000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39369000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39369000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,167290000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,83892000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25345000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,109237000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,58053000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-21840000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18740000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,39313000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7517000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31796000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31798000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31798000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45179000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45816000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.71
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,840883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,840883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,151305000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,151305000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,689578000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,341600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,98759000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,440359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,249219000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4561000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,256825000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,53816000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,203009000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,203009000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,203009000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45179000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.49
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45816000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.43
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.49
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,634224000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,634224000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,111936000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,111936000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,522288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,257708000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,73414000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,331122000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,191166000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9067000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17279000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26346000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,217512000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46299000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,171213000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,171211000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,171211000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.79
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45695000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.72
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.79
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,841305000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,841305000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,146784000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,146784000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,694521000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,339004000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,98962000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,437966000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,256555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11836000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,47651000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,59487000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,316042000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,70895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,245147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,245172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,245172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.43
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45695000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.32
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.43
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,221584000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,221584000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39996000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39996000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,181588000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,85674000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25655000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111329000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,70259000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3086000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,23671000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26757000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,97016000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27799000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,69217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,69217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.53
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45695000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.51
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,2020-02-06 16:07:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.53
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,412640000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,412640000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,71940000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,71940000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,340700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,172034000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47759000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,219793000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,120907000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5981000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6392000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-411000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,120496000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,101996000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,101994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,101994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45319000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45912000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,820284000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,820284000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,140811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,140811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,679473000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,333550000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,97272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,430822000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,248651000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10925000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,23960000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,34885000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,283536000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,62744000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,220792000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,220817000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,220817000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45319000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.9
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45912000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.78
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.9
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,204974000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,204974000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34867000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34867000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,170107000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,85956000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23969000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,109925000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60182000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2932000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-45756000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-42824000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17358000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13058000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13071000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13071000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45319000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45912000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,2019-10-31 16:13:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,797088000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,797088000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,135790000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,135790000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,661298000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,326489000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,96020000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,422509000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,238789000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9664000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,69558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,79222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,318011000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,60144000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,257867000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,257873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,257873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.72
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46092000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.59
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.72
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,207666000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,207666000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37073000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37073000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,170593000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,86078000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23790000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,109868000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60725000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3049000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39364000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,42413000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,103138000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,88938000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,88923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,88923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.97
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46092000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.93
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.97
